ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2022

Affibody-Mediated PNA-Based Pretargeted Cotreatment Improves Survival of Trastuzumab-Treated Mice Bearing HER2-Expressing Xenografts.

Maryam Oroujeni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.